Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

48.03 +0.49 (+1.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist

Other Filings

Form DEF 14A
Source: SEC/Edgar
March 22, 2016
Form DEFA14A
Source: SEC/Edgar
March 22, 2016
Form 8-K
Source: SEC/Edgar
March 06, 2016
Form 8-K
Source: SEC/Edgar
February 28, 2016
Form SC 13G/A
Source: SEC/Edgar
February 10, 2016
Form SC 13G/A
Source: SEC/Edgar
February 08, 2016
Form 8-K
Source: SEC/Edgar
January 25, 2016
Form SC 13G/A
Source: SEC/Edgar
January 25, 2016
Form SC 13G/A
Source: SEC/Edgar
January 25, 2016
Form 8-K
Source: SEC/Edgar
January 10, 2016
Form 8-K
Source: SEC/Edgar
January 03, 2016
Form 8-K
Source: SEC/Edgar
November 08, 2015
Form 10-Q/A
Source: SEC/Edgar
August 10, 2015
Form S-8
Source: SEC/Edgar
August 09, 2015
Form 8-K
Source: SEC/Edgar
August 09, 2015
Form 8-K
Source: SEC/Edgar
August 05, 2015
Form SC 13G/A
Source: SEC/Edgar
June 08, 2015
Form 8-K
Source: SEC/Edgar
June 04, 2015
Form 8-K
Source: SEC/Edgar
May 10, 2015
Form 8-K
Source: SEC/Edgar
May 10, 2015
Form DEF 14A
Source: SEC/Edgar
April 02, 2015
Form 8-K
Source: SEC/Edgar
March 01, 2015
Form SC 13G/A
Source: SEC/Edgar
February 16, 2015
Form SC 13G/A
Source: SEC/Edgar
February 12, 2015
Form SC 13G
Source: SEC/Edgar
February 10, 2015
Form SC 13G/A
Source: SEC/Edgar
January 29, 2015
Form SC 13G
Source: SEC/Edgar
January 28, 2015
Form 8-K
Source: SEC/Edgar
January 25, 2015
Form 8-K
Source: SEC/Edgar
January 20, 2015
Form 8-K
Source: SEC/Edgar
January 11, 2015
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.